264: Research funding is being slashed. What’s the real industry impact?
Description
In the past several months, the Trump administration has frozen, cancelled, or rescinded millions—even billions—of dollars in federal funding for scientific and clinical research. This is funding that flows directly from bodies like the NIH to universities, academic medical centers, and others to facilitate basic science research, translational research, public health initiatives, and more.
Frankly, many organizations did not see these cuts coming—at least not at this scale. And the impacts are likely to touch most every corner of the industry.
This week, host Abby Burns sits down with Advisory Board experts Emily Heuser and Gaby Marmolejos to dig into how these cuts are being orchestrated and the ripple effects they may cause across—and even beyond—the healthcare industry.
We’re here to help:
- Read: How research funding cuts are impacting healthcare (and how to respond)
- Check out: Healthcare policy updates
- Check out: Philanthropy
- Keep track: Healthcare Policy Updates Timeline
- Use our tool: How policy changes will impact your bottom line
- Research Membership
- Grant Witness
Navigating healthcare’s next frontier: 5 takeaways from the CHG Healthcare Executive Summit
A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.
![[Encore] How hospitals and post-acute providers can rebuild their relationships (and why they need to)](https://s3.castbox.fm/50/d5/42/ed7e3fc61816c8b17b9cfe220054e2e2d2_scaled_v1_400.jpg "[Encore] How hospitals and post-acute providers can rebuild their relationships (and why they need to)")
United States
